A risk factor is something that increases your chance of developing cancer.
It is possible to develop thyroid cancer with or without the risk factors listed below. However, the more risk factors you have, the greater your likelihood of developing thyroid cancer. If you have a number of risk factors, ask your healthcare provider what you can do to reduce your risk.
Risk factors for thyroid cancer include the following:
Although thyroid cancer can occur at any age, the majority of people diagnosed with this condition are over the age of 40. Most people diagnosed with anaplastic thyroid cancer are over age 60.
Except for medullary cancer, women are about three times as likely as men to develop thyroid cancer.
Family History and Genetic Makeup
Medullary thyroid cancer sometimes runs in families as part of a syndrome called multiple endocrine neoplasia. Families with a history of goiter development or
also have a tendency to develop papillary thyroid cancer. You are particularly at risk of developing endocrine cancers, such as medullary thyroid cancer, if you have a certain kind of genetic change (mutation) in something called the RET gene.
Exposure to Radiation
A history of exposure to radiation (especially during childhood) is a very strong risk factor for the development of thyroid cancer. Exposure may have occurred during medical treatments (for example, during radiation treatments for acne or enlarged tonsils, as was performed between the 1920s and the 1950s in the United States) or due to accidental exposure to radioactive fallout from nuclear power plant accidents, such as the one that occurred in Chernobyl, Russia.
Iodine is necessary for thyroid hormone production. Without enough iodine, the thyroid enlarges to form a mass called a goiter. In the United States, iodine is commonly added to table salt, preventing most Americans from being deficient. In areas of the world where iodine deficiency occurs more frequently, there are higher rates of goiter, as well as thyroid cancer.
Incidence of thyroid cancer is highest in the Hawaiian and Polynesian islands and lowest in Poland.
Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma.
Cooper DS, Doherty GM, Haugen BR et al: The American Thyroid Association Guidelines Taskforce: management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
Cornett WR, Sharma AK, Day TA, et al. Anaplastic thyroid carcinoma: an overview.
Curr Oncol Rep.
Rachmiel M, Charron M, Gupta A, et al. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma.
J Pediatr Endocrinol Metab.
Please be aware that this information is provided to supplement the care
provided by your physician. It is neither intended nor implied to be a
substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER
IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the
advice of your physician or other qualified health provider prior to
starting any new treatment or with any questions you may have regarding a